Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_assertion type Assertion NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_head.
- NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_assertion description "[We now report that our NSCLC MHC II vaccines prepared from adeno, squamous or large cell carcinomas each activate CD4(+) T cells that cross-react with the other NSCLC subtypes and do not react with HLA-DR-matched normal lung fibroblasts or other HLA-DR-matched nonlung tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_provenance.
- NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_assertion evidence source_evidence_literature NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_provenance.
- NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_assertion SIO_000772 20473949 NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_provenance.
- NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_assertion wasDerivedFrom befree-20140225 NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_provenance.
- NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_assertion wasGeneratedBy ECO_0000203 NP374660.RANGF9XjS821-FtfgtqioWofr1uG2aI7w59ANrLPo52v4130_provenance.